黑色素-话题@MedSci

#黑色素#

1110篇内容 | 2796人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1565024, encodeId=0bc11565024af, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=针对抗PD-1/PD-L1治疗后进展的黑色素瘤：G蛋白雌激素受体激动剂LNS8801获得FDA快速通道, objectType=article, longId=196199, objectId=04db19619962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04db19619962, replyNumber=0, likeNumber=47, createdTime=2020-06-22, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04db19619962, moduleTitle=针对抗PD-1/PD-L1治疗后进展的黑色素瘤：G蛋白雌激素受体激动剂LNS8801获得FDA快速通道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04db19619962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559015, encodeId=c2a115590159b, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=针对抗PD-1/PD-L1治疗后进展的黑色素瘤：G蛋白雌激素受体激动剂LNS8801获得FDA快速通道, objectType=article, longId=196199, objectId=04db19619962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04db19619962, replyNumber=0, likeNumber=68, createdTime=2020-06-22, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04db19619962, moduleTitle=针对抗PD-1/PD-L1治疗后进展的黑色素瘤：G蛋白雌激素受体激动剂LNS8801获得FDA快速通道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04db19619962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565023, encodeId=865b1565023af, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Lancet：Atezolizumab-Vemurafenib-Cobimetinib一线治疗晚期BRAF V600突变阳性黑色素瘤, objectType=article, longId=195816, objectId=65141958168d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65141958168d, replyNumber=0, likeNumber=76, createdTime=2020-06-15, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65141958168d, moduleTitle=Lancet：Atezolizumab-Vemurafenib-Cobimetinib一线治疗晚期BRAF V600突变阳性黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65141958168d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559014, encodeId=d671155901429, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Lancet：Atezolizumab-Vemurafenib-Cobimetinib一线治疗晚期BRAF V600突变阳性黑色素瘤, objectType=article, longId=195816, objectId=65141958168d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65141958168d, replyNumber=0, likeNumber=74, createdTime=2020-06-15, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65141958168d, moduleTitle=Lancet：Atezolizumab-Vemurafenib-Cobimetinib一线治疗晚期BRAF V600突变阳性黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65141958168d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565022, encodeId=a6601565022eb, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Aging：黑色素瘤的新型免疫相关基因预后生物标志物：与肿瘤微环境相关, objectType=article, longId=194771, objectId=f72f194e7116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f72f194e7116, replyNumber=0, likeNumber=81, createdTime=2020-05-28, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f72f194e7116, moduleTitle=Aging：黑色素瘤的新型免疫相关基因预后生物标志物：与肿瘤微环境相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f72f194e7116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559013, encodeId=12aa1559013ef, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Aging：黑色素瘤的新型免疫相关基因预后生物标志物：与肿瘤微环境相关, objectType=article, longId=194771, objectId=f72f194e7116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f72f194e7116, replyNumber=0, likeNumber=69, createdTime=2020-05-28, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f72f194e7116, moduleTitle=Aging：黑色素瘤的新型免疫相关基因预后生物标志物：与肿瘤微环境相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f72f194e7116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565021, encodeId=636815650217d, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=NAT MED：阿尔兹海默症保护基因竟然促进黑色素瘤转移, objectType=article, longId=194751, objectId=536d194e5107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=536d194e5107, replyNumber=0, likeNumber=99, createdTime=2020-05-28, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=536d194e5107, moduleTitle=NAT MED：阿尔兹海默症保护基因竟然促进黑色素瘤转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=536d194e5107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559012, encodeId=af841559012a0, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=NAT MED：阿尔兹海默症保护基因竟然促进黑色素瘤转移, objectType=article, longId=194751, objectId=536d194e5107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=536d194e5107, replyNumber=0, likeNumber=85, createdTime=2020-05-28, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=536d194e5107, moduleTitle=NAT MED：阿尔兹海默症保护基因竟然促进黑色素瘤转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=536d194e5107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565020, encodeId=0e2315650209e, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=ARCH PATHOL LAB MED：结膜黑色素痣与颗粒细胞改变, objectType=article, longId=194493, objectId=0f2419449384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f2419449384, replyNumber=0, likeNumber=64, createdTime=2020-05-22, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f2419449384, moduleTitle=ARCH PATHOL LAB MED：结膜黑色素痣与颗粒细胞改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f2419449384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559011, encodeId=48fa1559011a1, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=ARCH PATHOL LAB MED：结膜黑色素痣与颗粒细胞改变, objectType=article, longId=194493, objectId=0f2419449384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f2419449384, replyNumber=0, likeNumber=69, createdTime=2020-05-22, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f2419449384, moduleTitle=ARCH PATHOL LAB MED：结膜黑色素痣与颗粒细胞改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f2419449384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565019, encodeId=c41215650199f, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=腹透液检查竟发现恶性黑色素瘤细胞！, objectType=article, longId=194470, objectId=3fef1944e0fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fef1944e0fb, replyNumber=0, likeNumber=55, createdTime=2020-05-22, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fef1944e0fb, moduleTitle=腹透液检查竟发现恶性黑色素瘤细胞！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fef1944e0fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559010, encodeId=acd2155901014, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=腹透液检查竟发现恶性黑色素瘤细胞！, objectType=article, longId=194470, objectId=3fef1944e0fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fef1944e0fb, replyNumber=0, likeNumber=66, createdTime=2020-05-22, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fef1944e0fb, moduleTitle=腹透液检查竟发现恶性黑色素瘤细胞！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fef1944e0fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565018, encodeId=42d5156501890, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Lancet：Nivolumab用于IV期黑色素瘤的治疗, objectType=article, longId=194244, objectId=c4ff19424468, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4ff19424468, replyNumber=0, likeNumber=79, createdTime=2020-05-17, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4ff19424468, moduleTitle=Lancet：Nivolumab用于IV期黑色素瘤的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4ff19424468)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559009, encodeId=59a81559009bd, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Lancet：Nivolumab用于IV期黑色素瘤的治疗, objectType=article, longId=194244, objectId=c4ff19424468, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4ff19424468, replyNumber=0, likeNumber=58, createdTime=2020-05-17, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4ff19424468, moduleTitle=Lancet：Nivolumab用于IV期黑色素瘤的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4ff19424468)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565017, encodeId=5162156501e7d, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Cell Death Dis：环状RNA Circ_0002770高表达预示黑色素瘤患者预后不良, objectType=article, longId=193915, objectId=54c41939154a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54c41939154a, replyNumber=0, likeNumber=84, createdTime=2020-05-12, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54c41939154a, moduleTitle=Cell Death Dis：环状RNA Circ_0002770高表达预示黑色素瘤患者预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54c41939154a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559008, encodeId=86561559008d7, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Cell Death Dis：环状RNA Circ_0002770高表达预示黑色素瘤患者预后不良, objectType=article, longId=193915, objectId=54c41939154a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54c41939154a, replyNumber=0, likeNumber=64, createdTime=2020-05-12, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54c41939154a, moduleTitle=Cell Death Dis：环状RNA Circ_0002770高表达预示黑色素瘤患者预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54c41939154a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559007, encodeId=8dd1155900e73, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Cell Death Dis：STAT3激活参与TLR4介导的黑色素瘤发生发展, objectType=article, longId=193375, objectId=0f851933e5d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f851933e5d6, replyNumber=0, likeNumber=13, createdTime=2020-05-03, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f851933e5d6, moduleTitle=Cell Death Dis：STAT3激活参与TLR4介导的黑色素瘤发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f851933e5d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565016, encodeId=fdd515650166c, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=Cell Death Dis：STAT3激活参与TLR4介导的黑色素瘤发生发展, objectType=article, longId=193375, objectId=0f851933e5d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f851933e5d6, replyNumber=0, likeNumber=16, createdTime=2020-05-03, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f851933e5d6, moduleTitle=Cell Death Dis：STAT3激活参与TLR4介导的黑色素瘤发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f851933e5d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565015, encodeId=e12515650156a, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=AACR 2020：靶向联合免疫治疗显著延长BRAF突变晚期黑色素瘤患者无进展生存（IMspire150试验）, objectType=article, longId=193346, objectId=688d193346bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=688d193346bb, replyNumber=0, likeNumber=85, createdTime=2020-05-03, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=688d193346bb, moduleTitle=AACR 2020：靶向联合免疫治疗显著延长BRAF突变晚期黑色素瘤患者无进展生存（IMspire150试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=688d193346bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559006, encodeId=9fac15590062e, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, objectTitle=AACR 2020：靶向联合免疫治疗显著延长BRAF突变晚期黑色素瘤患者无进展生存（IMspire150试验）, objectType=article, longId=193346, objectId=688d193346bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=688d193346bb, replyNumber=0, likeNumber=62, createdTime=2020-05-03, rootId=0, userName=cqlidoudou, userId=150614999302, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=688d193346bb, moduleTitle=AACR 2020：靶向联合免疫治疗显著延长BRAF突变晚期黑色素瘤患者无进展生存（IMspire150试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=688d193346bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

黑色素

2020-05-29

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

针对抗PD-1/PD-L1治疗后进展的黑色素瘤：G蛋白雌激素受体激动剂LNS8801获得FDA快速通道

2020-06-22

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

针对抗PD-1/PD-L1治疗后进展的黑色素瘤：G蛋白雌激素受体激动剂LNS8801获得FDA快速通道

2020-06-22

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Lancet：Atezolizumab-Vemurafenib-Cobimetinib一线治疗晚期BRAF V600突变阳性黑色素瘤

2020-06-15

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Lancet：Atezolizumab-Vemurafenib-Cobimetinib一线治疗晚期BRAF V600突变阳性黑色素瘤

2020-06-15

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Aging：黑色素瘤的新型免疫相关基因预后生物标志物：与肿瘤微环境相关

2020-05-28

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Aging：黑色素瘤的新型免疫相关基因预后生物标志物：与肿瘤微环境相关

2020-05-28

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

NAT MED：阿尔兹海默症保护基因竟然促进黑色素瘤转移

2020-05-28

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

NAT MED：阿尔兹海默症保护基因竟然促进黑色素瘤转移

2020-05-28

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

ARCH PATHOL LAB MED：结膜黑色素痣与颗粒细胞改变

2020-05-22

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

ARCH PATHOL LAB MED：结膜黑色素痣与颗粒细胞改变

2020-05-22

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

腹透液检查竟发现恶性黑色素瘤细胞！

2020-05-22

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

腹透液检查竟发现恶性黑色素瘤细胞！

2020-05-22

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Lancet：Nivolumab用于IV期黑色素瘤的治疗

2020-05-17

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Lancet：Nivolumab用于IV期黑色素瘤的治疗

2020-05-17

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Cell Death Dis：环状RNA Circ_0002770高表达预示黑色素瘤患者预后不良

2020-05-12

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Cell Death Dis：环状RNA Circ_0002770高表达预示黑色素瘤患者预后不良

2020-05-12

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Cell Death Dis：STAT3激活参与TLR4介导的黑色素瘤发生发展

2020-05-03

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

Cell Death Dis：STAT3激活参与TLR4介导的黑色素瘤发生发展

2020-05-03

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

AACR 2020：靶向联合免疫治疗显著延长BRAF突变晚期黑色素瘤患者无进展生存（IMspire150试验）

2020-05-03

cqlidoudou (审核中...)

前往app查看评论内容

#黑色素#

AACR 2020：靶向联合免疫治疗显著延长BRAF突变晚期黑色素瘤患者无进展生存（IMspire150试验）

2020-05-03

科室
- - 订阅+
  - 更多科室
工具
服务